Arizona State Retirement System Raises Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Arizona State Retirement System grew its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,900 shares of the company’s stock after buying an additional 264 shares during the quarter. Arizona State Retirement System’s holdings in Prestige Consumer Healthcare were worth $957,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Congress Asset Management Co. MA lifted its position in Prestige Consumer Healthcare by 596.2% in the 4th quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock valued at $41,584,000 after acquiring an additional 581,685 shares in the last quarter. Norges Bank bought a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at $27,739,000. Allspring Global Investments Holdings LLC boosted its position in shares of Prestige Consumer Healthcare by 26.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after buying an additional 272,773 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Prestige Consumer Healthcare by 9.0% in the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after buying an additional 171,357 shares in the last quarter. Finally, F M Investments LLC purchased a new position in Prestige Consumer Healthcare in the 2nd quarter worth about $11,162,000. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $74.12 on Friday. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $3.67 billion, a PE ratio of 17.77, a price-to-earnings-growth ratio of 2.01 and a beta of 0.48. The firm’s 50 day moving average price is $70.77 and its 200-day moving average price is $69.56. Prestige Consumer Healthcare Inc. has a twelve month low of $56.34 and a twelve month high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. During the same period last year, the firm earned $1.06 earnings per share. The company’s quarterly revenue was down 4.4% on a year-over-year basis. Equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Analysts Set New Price Targets

PBH has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, May 21st. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $80.00 target price on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. Finally, DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $98.75.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.